Actionable news
All posts from Actionable news
Actionable news in LLY: ELI LILLY & CO.,

Jim Cramer — Regeneron's Rally Is Going to Boost Biotechs

NEW YORK (TheStreet) -- Eli Lilly (LLY - Get Report) shares are down an unhealthy 7% Monday after the company said it is shutting down trials on its cholesterol-lowering treatment.

This is going to give a big boost to other biotechs developing cholesterol treatments, specifically Regeneron (REGN - Get Report) and Amgen (AMGN - Get Report) , TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said on CNBC's "Mad Dash" segment.

Regeneron shares are up over 4% while Amgen's are up...